2016-03-29 18:49:15 UTC

Comparison of Two Studies of UES Assist Device for Treatment of Extraesophageal Reflux

Duration

15 minutes

About

A four week trial compares the safety and effectiveness of UES Assist Device for patients with chronic extraesophageal reflux symptoms when treated by otolaryngologists and gastroenterologists.  

Presented at Digestive Disease Week®, May 16-19, 2015, Walter E. Washington Convention Center, Washington, DC

About the Instructors

Michael F. Vaezi, MD, PhD, MSc; Stacey L. Silvers, MD; Namish B. Vakil, MD, FACG, FACP, AGAF, FASGE; Alan R. Raymond, MD; Michael J. Schmalz, MD, FACG; James S. Miller, BS; and Nicholas T. Maris, MBA.

This is only a preview. Full access is reserved for AGA members. Login or learn more about becoming a member.

Login

More on GERD

More Data on PPI Use and Kidney Disease

Nov. 8, 2017

A new meta-analysis on PPIs and kidney disease makes mainstream headlines. Here is what you, and your patients, need to know.

New PPI Study on Gastric Cancer Generates Media Attention

Nov. 2, 2017

AGA provides talking points to help your patients understand the science behind the PPI study.

Image Challenge: Chronic Abdominal Pain and Cutaneous Swelling

Sept. 27, 2017

What caused five to eight week episodes of intermittent abdominal pain, diarrhea, and associated nontender, non-itchy cutaneous erythema and swelling in patient?